Pulmo BioTech's Subsidiary Completes Bio-Distribution Studies
Posted on: Tuesday, 8 July 2008, 09:00 CDT
Pulmo BioTech has announced that its subsidiary, PulmoScience has completed the bio-distribution studies on its DFH-12 product candidate for the PulmoBind technology of molecular imaging of the vascular system of the lungs.
The in- vivo studies have shown that the molecule is predominantly retained in the lungs 30 minutes after injection with only minor retention in the liver and heart.
Further bio-distribution studies have also shown that after 240 minutes the majority of the injected molecules have been eliminated through the kidneys and bladder.
Source: Datamonitor
Related Articles
- The State of Elementary Social Studies Teaching in One Urban District
- Portraits of Practices in Social Studies Methods Courses
- Impact of a High School Graduation Examination on Social Studies Teachers' Instructional Practices
- Brain Study Examines How People Feel Pain
- Ancient oceans lacked oxygen essential for life, study shows
- Blacks' DNA to Be Used in Disease Study
- Boeing Studies Keep ISS Humming
- Antidepressant Study Needs Mexican Volunteers
- Bear Study May Aid Osteoporosis Research
- Alzheimer's Studies Look at Role of Fats
Rate this article:
User Comments (0)
RSS Feeds